Johnson et al. “Fragment-Based Discovery of Type I Inhibitors of Maternal Embryonic Leucine Zipper Kinase.” ACS Medicinal Chemistry Letters, DOI:10.1021/ml5001245

/in , ,

Johnson et al. “Fragment-Based Discovery of Type I Inhibitors of Maternal Embryonic Leucine Zipper Kinase.” ACS Medicinal Chemistry Letters, DOI:10.1021/ml5001245

Howard et al. “Fragment-Based Discovery of 6-Azaindazoles As Inhibitors of Bacterial DNA Ligase.” ACS Medicinal Chemistry Letters (2013). DOI: 10.1021/ml4003277 .

/in ,

Howard et al. “Fragment-Based Discovery of 6-Azaindazoles As Inhibitors of Bacterial DNA Ligase.” ACS Medicinal Chemistry Letters (2013). DOI: 10.1021/ml4003277 .

Jhoti et al.. “The ‘rule of three’ for fragment-based drug discovery: where are we now?.” Nature Reviews Drug Discovery (2013). DOI: DOI:10.1038/nrd3926-c1 .

/in ,

Jhoti et al.. “The ‘rule of three’ for fragment-based drug discovery: where are we now?.” Nature Reviews Drug Discovery (2013). DOI: DOI:10.1038/nrd3926-c1 .

Crawford et al.. “SAHA abrogates FLIP-mediated inhibition of SMAC mimetic-induced apoptosis in mesothelioma.” Cell Death Dis. 2013 Jul; 4(7): e733 .

/in ,

Crawford et al.. “SAHA abrogates FLIP-mediated inhibition of SMAC mimetic-induced apoptosis in mesothelioma.” Cell Death Dis. 2013 Jul; 4(7): e733 .

Chaneton, et al. “Serine is a natural ligand and allosteric activator of pyruvate kinase M2.” Nature 2012. DOI: 10.1038/nature11540.

/in ,

Chaneton, et al. “Serine is a natural ligand and allosteric activator of pyruvate kinase M2.” Nature 2012. DOI: 10.1038/nature11540.

Saalau-Bethell, et al. “Discovery of an allosteric mechanism for the regulation of HCV NS3 protein function.” Nature Chemical Biology 2012. DOI: 10.1038/NCHEMBIO.1081.

/in ,

Saalau-Bethell, et al. “Discovery of an allosteric mechanism for the regulation of HCV NS3 protein function.” Nature Chemical Biology 2012. DOI: 10.1038/NCHEMBIO.1081.

Thomas G. Davies and Ian J. Tickle. “Fragment Screening Using X-Ray Crystallography.” Topics in Current Chemistry 317 2012: 33-59. DOI: 10.1007/128_2011_179.

/in ,

Thomas G. Davies and Ian J. Tickle. “Fragment Screening Using X-Ray Crystallography.” Topics in Current Chemistry 317 2012: 33-59. DOI: 10.1007/128_2011_179.

The HSP90 Inhibitor, AT13387, is Effective Against Imatinib-Sensitve and -Resistant Gastrointestinal Stromal Tumours

/in ,

Smyth et al.. “The HSP90 Inhibitor, AT13387, is Effective Against Imatinib-Sensitve and -Resistant Gastrointestinal Stromal Tumours.” Mol Cancer Ther 2012;11:1799-1808 .